EVE is a consortium comprised of all U.S. investigators who have conducted genome-wide association studies (GWAS) of asthma and whose main objective is to combine results of individual studies to increase the overall power to identify asthma-susceptibility loci. The consortium includes investigators at 10 U.S. institutions with GWAS results for >30,000 individuals representing European American, African American, U.S. Hispanic, and Mexican populations. As part of the initial goals of EVE, investigators aim to develop a common set of >1 million genotyped and imputed SNPs to be tested for association with asthma in this primary sample followed by association statistics to be combined in a grand meta-analysis for asthma gene discovery. In this GO application, we propose four specific aims: 1) to replicate the most significant meta-analysis results in >15,000 asthma cases and controls of European American, African American, and U.S. Hispanic ethnicities;2) to resequence 5-10 genes associated with asthma in European Americans but not in African Americans or Hispanic cases and controls (>1,500 individuals) to identify rare and common variants that are not well-tagged by SNPs on the genotyping platforms;3) to conduct additional meta-analyses in the primary sample for asthma associated phenotypes (e.g., measures of lung function, total serum IgE), and to examine interactions with sex, tobacco smoke exposure in infancy, and between genes;and 4) to develop methods that combine data from different types of study samples (case-control, trios, cohorts) for the meta-analyses described in Aim 3, and integrate network and pathway analyses into our approaches for gene discovery. Discovery of risk alleles for asthma and its associated phenotypes could significantly impact public health and health care delivery by allowing for population screening to identify at-risk individuals who could be candidates for early intervention (disease prevention) or for personalized therapeutics based on molecular pathology rather than on symptomology (disease treatment).

Public Health Relevance

EVE is a consortium comprised of all U.S. investigators who have conducted genome-wide association studies (GWAS) of asthma and whose main objective is to combine results of individual studies to increase the overall power to identify asthma-susceptibility loci. The consortium includes investigators at 10 U.S. institutions with GWAS results for >30,000 individuals representing European American, African American, U.S. Hispanic, and Mexican populations. In this application, we propose to replicate the most significant GWAS results in >15,000 asthma cases and controls of European American, African American, and U.S. Hispanic ethnicities, resequence 5-10 genes associated with asthma in European Americans but not in African Americans or Hispanic cases and controls, to study additional asthma-associated phenotypes and examine interactions, and develop methods to facilitate gene discovery. Discovery of risk alleles for asthma and its associated phenotypes could significantly impact public health and health care delivery.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
High Impact Research and Research Infrastructure Programs (RC2)
Project #
1RC2HL101651-01
Application #
7855517
Study Section
Special Emphasis Panel (ZHL1-CSR-R (O4))
Program Officer
Banks-Schlegel, Susan P
Project Start
2009-09-30
Project End
2011-08-31
Budget Start
2009-09-30
Budget End
2010-08-31
Support Year
1
Fiscal Year
2009
Total Cost
$5,646,401
Indirect Cost
Name
University of Chicago
Department
Genetics
Type
Schools of Medicine
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Demenais, Florence; Margaritte-Jeannin, Patricia; Barnes, Kathleen C et al. (2018) Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks. Nat Genet 50:42-53
Panganiban, Ronald A; Sun, Maoyun; Dahlin, Amber et al. (2018) A functional splice variant associated with decreased asthma risk abolishes the ability of gasdermin B to induce epithelial cell pyroptosis. J Allergy Clin Immunol 142:1469-1478.e2
Lareau, C A; DeWeese, C F; Adrianto, I et al. (2017) Polygenic risk assessment reveals pleiotropy between sarcoidosis and inflammatory disorders in the context of genetic ancestry. Genes Immun 18:88-94
Johnston, Henry Richard; Hu, Yi-Juan; Gao, Jingjing et al. (2017) Identifying tagging SNPs for African specific genetic variation from the African Diaspora Genome. Sci Rep 7:46398
Kessler, Michael D; Yerges-Armstrong, Laura; Taub, Margaret A et al. (2016) Challenges and disparities in the application of personalized genomic medicine to populations with African ancestry. Nat Commun 7:12521
Bønnelykke, Klaus; Ober, Carole (2016) Leveraging gene-environment interactions and endotypes for asthma gene discovery. J Allergy Clin Immunol 137:667-79
Mathias, Rasika Ann; Taub, Margaret A; Gignoux, Christopher R et al. (2016) A continuum of admixture in the Western Hemisphere revealed by the African Diaspora genome. Nat Commun 7:12522
Acosta-Herrera, Marialbert; Pino-Yanes, Maria; Ma, Shwu-Fan et al. (2015) Fine mapping of the myosin light chain kinase (MYLK) gene replicates the association with asthma in populations of Spanish descent. J Allergy Clin Immunol 136:1116-8.e9
Pino-Yanes, Maria; Gignoux, Christopher R; Galanter, Joshua M et al. (2015) Genome-wide association study and admixture mapping reveal new loci associated with total IgE levels in Latinos. J Allergy Clin Immunol 135:1502-10
Auer, Paul L; Nalls, Mike; Meschia, James F et al. (2015) Rare and Coding Region Genetic Variants Associated With Risk of Ischemic Stroke: The NHLBI Exome Sequence Project. JAMA Neurol 72:781-8

Showing the most recent 10 out of 40 publications